Answers are grounded in this paper and cite their sources.
Review uncovers multicellular network drivers of hyperinflammation and immunoparalysis in sepsis, indicating precision immunotherapy requires distinguishing immune tolerance from immunoparalysis.
Sepsis is defined by a dysregulated host immune response that encompasses both hyperinflammation and concurrent immunoparalysis. Rather than isolated cell defects, a dynamic multicellular network—involving neutrophils, macrophages, T cells, dendritic cells, and platelets—drives this maladaptive state through cytokine and metabolic crosstalk. Here, we review how cell-cell interactions within this network promote the transition from acute inflammation to sustained organ dysfunction, and we outline emerging precision strategies, including immune checkpoint modulation, metabolic intervention, and biomarker-guided timing, that target critical network nodes. We further highlight the fundamental distinction between PPAR-mediated immune tolerance, which preserves antimicrobial competence, and pathological immunoparalysis marked by reduced monocyte HLA-DR expression, arguing that their differential recognition is essential for matching therapy to immune trajectory. Integrating these network-based approaches into clinical practice holds the promise of rebalancing immunity and improving outcomes in sepsis. Not applicable.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: